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Surgical Techniquesundergoing multiple redo mitral valve surgery. A right tho-
racotomy requires minimal retraction and dissection of the
heart and provides good exposure of the mitral valve.
Cardiopulmonary bypass on ventricular fibrillation can de-
crease the manipulation of the aorta without aortic cannula-
tion and cross-clamps. The disadvantage of this approach is
the increased risk of cerebral vascular insufficiency.5 Fem-
oral arterial cannulation can cause stroke if the aorta has
atherosclerotic changes. When the femoral artery is un-
available, arterial cannulation can be achieved using the
right subclavian artery. Because air embolism is also a cause
of stroke, vent placement across the aortic root and carbon
dioxide flooding of the thoracic cavity are recommended to
remove air from the heart. The repeat leak incidence after
surgical treatment of mitral PVL has been reported to be
22%.1 For PVL repair without repeat replacement, the
leak size and location should be defined accurately by pre-
operative transesophageal echocardiography. In the present
cases, we decided that their PVLs could be treated using this
technique because of the small leak size and number. If the
size is large or multiple leaks are present, repeat MVRFrom the Divisions of Cardiac Surgery,a and Cardiology,b University of Padova, Italy.
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The Journal of Thoracic and Carmight be adequate for PVL treatment. A durable repair
technique is also necessary for PVL closure. We present
a double-closure technique for mitral PVL repair with
both pledgeted sutures and a pericardial patch that might
provide greater durability. Even if the mitral annulus be-
comes detached from the sewing ring, the patch will prevent
recurrence of the leak. This technique provides an easy ap-
proach to the mitral valve, with durable repair of the leak
and is 1 of the feasible options for patients undergoing sur-
gery for mitral PVL.
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reoperation? J Thorac Cardiovasc Surg. 2007;134:677-82.Transaortic balloon-expandable aortic valve implantationGino Gerosa, MD,a Assunta Fabozzo, MD,a Roberto Bianco, MD,a Giuseppe Tarantini, MD,b and
Augusto D’Onofrio, MD,a Padova, ItalyIn patients with severe symptomatic aortic valve stenosis
who are inoperable or at high risk for surgical aortic valve
replacement, transcatheter aortic valve implantation
(TAVI) represents an alternative therapeutic strategy.1 Cur-
rently, there are 2 commercially available devices: the self-
expandable CoreValve revalving system (Medtronic Inc,
Minneapolis, Minn) and the balloon-expandable Sapien
XT valve (Edwards Lifesciences, Irvine, Calif). For the lat-
ter, a transapical approach is the first choice in case of un-
available femoral access. However, in patients with severe
left ventricular (LV) dysfunction, a surgical approach of
the apex can potentially further worsen heart contractility,
and the presence of an LV aneurysm with mural thrombicontraindicates the procedure. Bleiziffer and colleagues2
reported that 1 year after transapical TAVI, a new apical
hypo- or akinesia was present in up to 37% of patients,
and that because of the apical scar, a significant reduction
of the LV ejection fraction was found in 13% of patients.
In these patients with ‘‘no access,’’ a subclavian/axillary ap-
proach has been described,3 but it is not feasible in case
a 29-mm device is necessary or both subclavian arteries
are heavily calcified or extremely tortuous. A transaortic
implantation has been described using the CoreValve re-
valving system.4 We describe the technique for 29-mm Sa-
pien XT implantation via a transaortic access.CLINICAL SUMMARY
A 70-year-old man with severe symptomatic aortic valve
stenosis was admitted to the University of Padova for acute
pulmonary edema. His aortic valve area was 0.74 cm2, peak
and mean gradients were 38 and 21 mm Hg, respectively,
LVejection fraction was 22%, and end-diastolic volume in-
dex was 118 mL/m2. In this patient, the nature of LV dys-
function was related to the chronic occlusion of the right
coronary artery with a consequent akinesia of thediovascular Surgery c Volume 143, Number 6 1453
FIGURE 1. A, Intraoperative view of the Ascendra 2 sheath (Edwards Lifesciences, Irvine, Calif) introduced in the ascending aorta with 2 purse-string
sutures. B, Transaortic balloon aortic valvuloplasty. C, Transaortic Sapien XT (Edwards Lifesciences) valve deployment. D, Absence of aortic regurgitation
after balloon and guide wire retraction. E, Intraoperative transesophageal echocardiography shows correct positioning of the aortic valve prosthesis.
Surgical Techniquesdiaphragmatic ventricular wall and to the long-standing aor-
tic valve pathology that led to a diffuse ventricular hypoki-
nesia. The left coronary artery was normal, and there were
no ventricular aneurysms. A dobutamine stress echocardio-
gram showed a slight improvement of the LV ejection
fraction that reached 35% and an increase of peak trans-
aortic gradient that reached 58 mm Hg.
The patient’s comorbidities were severe chronic pulmo-
nary obstructive disease requiring daily use of bronchodila-
tors and steroids, diffuse arteriopathy, and a frail aspect.1454 The Journal of Thoracic and Cardiovascular SurLogistic European System for Cardiac Operative Risk Eval-
uationwas 23% and Society of Thoracic Surgeons’mortality
score was 11%. The patient was scheduled for TAVI.
Preoperative angiography and computed tomography
scan showed an aortic annulus diameter of 27 mm, severe
calcifications of the iliac-femoral vessels with a diameter
less than 5.5 mm, and small and tortuous subclavian/
axillary arteries. No calcifications of the ascending aorta
were visible on computed tomography scan and aortic
angiography.gery c June 2012
Surgical TechniquesAortic annulus diameter was confirmed by a transesopha-
geal echocardiography. With these preoperative findings,
we concluded that the only possible strategy was a 29-mm
Sapien XT implantation via a transaortic approach.
Under general anesthesia, a small anterior right thoracot-
omy was performed in the second intercostal space. After
opening and suspending the pericardium, the ascending
aorta was exposed. Two purse-string sutures with a diameter
of 1.5 cm were made with a 3-0 braided stitch and Teflon
pledget reinforcement.
Puncture of the aorta was performed in the middle of the
purse-string sutures. Under fluoroscopic guidance, an angio-
graphic guidewirewas inserted retrogradely through the aor-
tic valve in the left ventricle. Because the direction of the
guide wire is not perpendicular to the plane of the aortic
valve, particular attention should be given to avoid possible
lesions to the aortic sinuses and aortic wall. A 6F sheath
was then placed on the guide wire through the aortic valve
to exchange the guide wire with an extra-stiff one, following
the already described transfemoral implantation technique.5
The 26FAscendra 2 sheath (Edwards Lifesciences) was in-
serted in the ascending aorta (Figure 1, A) to perform subse-
quent balloon aortic valvuloplasty and valve deployment.
Aortic valvuloplasty was carried out with a 20-mm bal-
loon during 180 beats/min–induced ventricular tachycardia
(Figure 1, B). A 29-mm Sapien XT valve was prepared on
the Ascendra 2 delivery system with its inflow portion di-
rected toward the tip of the catheter (ie, in the opposite po-
sition of a transapical procedure).
The prosthesis was then placed in the correct position
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The Journal of Thoracic and Cardeployment was performed under induced ventricular tachy-
cardia (Figure 1, C). Correct valve positioning and the ab-
sence of residual aortic valve regurgitation were confirmed
bypostprocedural aortic angiography (Figure 1,D) and intra-
operative transesophageal echocardiography (Figure 1, E).
The sheath was then removed, and the aortic purse-string
sutures were tightened under induced ventricular tachycar-
dia. The patient had an uneventful recovery and was dis-
charged in good general and clinical conditions.CONCLUSIONS
Transaortic implantation of the Sapien XT valve using
the Ascendra 2 system via a small right anterior thora-
cotomy may represent a valid alternative for patients
with severe aortic valve stenosis who are not eligible
for surgical aortic valve replacement and who cannot
undergo a retrograde transarterial or a transapical TAVI.References
1. Leon MB, Smith CR, Mack M, Miller C, Moses JW, Svensson LG, et al. Trans-
catheter aortic valve implantation for aortic stenosis in patients who cannot un-
dergo surgery. N Engl J Med. 2010;363:1597-607.
2. Bleiziffer S, Piazza N, Mazzitelli D, Opitz A, Bauernschmitt R, Lange R. Apical-
access-related complications associated with trans-catheter aortic valve implanta-
tion. Eur J Cardiothorac Surg. 2011;40:469-74.
3. De Robertis F, Asgar A, Davies S, Delahunty N, Kelleher A, Trimlett R, et al. The
left axillary artery—a new approach for transcatheter aortic valve implantation.
Eur J Cardiothorac Surg. 2009;36:807-12.
4. Latsios G, Gerkens U, Grube E. Transaortic transcatheter aortic valve implanta-
tion: a novel approach for the truly ‘‘no-access option’’ patients. Catheter
Cardiovasc Interv. 2010;75:1129-36.
5. Cribier A, Litzler PY, Eltchaninoff H, Godin M, Tron C, Bauer F, Bessou JP. Tech-
nique of transcatheter aortic valve implantation with the Edwards-Sapien heart
valve using the transfemoral approach. Herz. 2009;34:347-56.A simplified technique for total anomalous pulmonary venous
connection repair associated with functional single ventricleNaritaka Kimura, MD, Ayumu Masuoka, MD, Toshiyuki Katogi, MD, and Takaaki Suzuki, MD, Saitama,
JapanSurgical repair of total anomalous pulmonary venous con-
nection (TAPVC) with single ventricle remains challenging
because of the risk of late pulmonary venous obstruction.1,2Since 2007, we have used the vertical vein to establish
the continuity between the common atrium and the
pulmonary vein without cutting into the pulmonary
venous confluence. This report describes the outcome
associated with this simplified technique for TAPVC repair.CLINICAL SUMMARY
Six patients with single ventricle and TAPVC underwent
TAPVC repair in the primary operation between October
2007 and September 2010. The institutional review board
at Saitama International Medical Center, Saitama Medical
University, Saitama, Japan, approved this retrospectivediovascular Surgery c Volume 143, Number 6 1455
